Mantle Cell Lymphoma: Clinical Trials

1 trial for Mantle Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Mantle Cell Lymphoma: new trials by email Literature Review of Mantle Cell Lymphoma trials Research Report on Mantle Cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EDOCH Alternating With DHAP for New Diagnosed Younger MCL
Etoposide, Doxorubicin, Dexamethasone - Mantle Cell Lymphoma
Phase 4CompletedInstitute of Hematology & Blood Diseases Hospital, China552016-01-012026-02-11

Narrower conditions

Lymphoma, Mantle-Cell (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Prednisone (1)  ·  Rituximab (1)  ·  Thalidomide (1)  ·  Vincristine (1)  ·  prednylidene (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (1)

Countries

China (1)

Top investigators

Shuhua Yi, Doc (1)